Loading…
2019 NHCA Annual Conference has ended
avatar for Dr Nigel Whittle

Dr Nigel Whittle

Plextek Ltd
Head, Medical & Healthcare
Cambridge, United Kingdom
Plextek has developed an innovative technology to detect early symptoms of hearing loss by reliable and repeatable measurement of Auditory Brainstem Responses (ABR), that can be incorporated into standard commercial earbuds. The patented technology has the potential to provide early warning of imminent auditory disorders including hearing loss and tinnitus.
This work was originally funded by a UK defence contract, and we are working with Cambridge University to enhance the capabilities of the technology.
Plextek will commercialise the technology through a number of parallel approaches in different market sectors, and welcome approaches from potential collaborators.

Thursday, February 7
 

7:30am PST

8:30am PST

9:45am PST

11:30am PST

1:00pm PST

2:15pm PST

5:30pm PST

 
Friday, February 8
 

7:00am PST

8:15am PST

9:05am PST

9:25am PST

9:45am PST

10:35am PST

12:05pm PST

1:30pm PST

1:50pm PST

2:10pm PST

2:30pm PST

3:00pm PST

3:40pm PST

5:00pm PST

6:00pm PST

 
Saturday, February 9
 

7:30am PST

9:00am PST

9:25am PST

10:10am PST

10:40am PST

11:10am PST

11:30am PST

12:00pm PST

2:25pm PST

3:35pm PST

3:55pm PST

4:15pm PST

4:35pm PST